X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (1674) 1674
Publication (73) 73
Newsletter (58) 58
Book Review (20) 20
Book Chapter (6) 6
Magazine Article (5) 5
Book / eBook (1) 1
Government Document (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
alprazolam (1182) 1182
humans (986) 986
male (899) 899
pharmacology & pharmacy (851) 851
adult (612) 612
female (591) 591
psychiatry (526) 526
alprazolam - pharmacology (446) 446
animals (416) 416
benzodiazepines (318) 318
middle aged (317) 317
diazepam (314) 314
neurosciences (302) 302
double-blind method (270) 270
rats (259) 259
anxiety (257) 257
dose-response relationship, drug (242) 242
anti-anxiety agents - pharmacology (220) 220
index medicus (211) 211
clinical neurology (192) 192
panic disorder (184) 184
alprazolam - therapeutic use (178) 178
alprazolam - administration & dosage (177) 177
pharmacokinetics (160) 160
anti-anxiety agents - therapeutic use (156) 156
drug interactions (152) 152
alprazolam - pharmacokinetics (146) 146
mice (141) 141
aged (131) 131
alprazolam - adverse effects (130) 130
adolescent (127) 127
benzodiazepines - pharmacology (122) 122
drugs (118) 118
lorazepam (114) 114
cross-over studies (110) 110
panic disorder - drug therapy (107) 107
time factors (107) 107
anxiety disorders - drug therapy (106) 106
benzodiazepine (105) 105
double-blind (104) 104
psychiatric status rating scales (103) 103
psychomotor performance - drug effects (101) 101
diazepam - pharmacology (97) 97
anti-anxiety agents - adverse effects (96) 96
benzodiazepines - therapeutic use (91) 91
placebo (91) 91
agoraphobia (89) 89
triazolam (87) 87
depression (85) 85
imipramine (84) 84
research (80) 80
efficacy (79) 79
administration, oral (78) 78
metabolism (77) 77
analysis of variance (75) 75
gaba (74) 74
kinetics (74) 74
midazolam (74) 74
pharmacology (74) 74
rats, sprague-dawley (74) 74
anti-anxiety agents - administration & dosage (73) 73
behavior, animal - drug effects (72) 72
panic disorder - psychology (69) 69
anti-anxiety agents - pharmacokinetics (67) 67
cytochrome p-450 cyp3a (67) 67
motor activity - drug effects (67) 67
alprazolam - blood (66) 66
analysis (66) 66
pharmacodynamics (66) 66
half-life (64) 64
anxiety - drug therapy (63) 63
benzodiazepines - adverse effects (63) 63
fluoxetine (62) 62
stress (61) 61
treatment outcome (61) 61
area under curve (60) 60
clinical trials as topic (60) 60
receptors, gaba-a - drug effects (60) 60
depressive disorder - drug therapy (59) 59
drug administration schedule (59) 59
panic - drug effects (58) 58
gaba modulators - pharmacology (57) 57
antidepressants (56) 56
pharmacology/toxicology (56) 56
clonazepam (55) 55
rat (55) 55
young adult (55) 55
healthy-volunteers (54) 54
rats, inbred strains (53) 53
memory (51) 51
brain (50) 50
hypnotics and sedatives - pharmacology (50) 50
performance (50) 50
rats, wistar (50) 50
toxicology (50) 50
in-vitro (49) 49
psychology (49) 49
chromatography, high pressure liquid (48) 48
cytochrome p-450 enzyme system - metabolism (48) 48
withdrawal (48) 48
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (1710) 1710
French (9) 9
Spanish (5) 5
Japanese (4) 4
Russian (4) 4
German (3) 3
Italian (2) 2
Chinese (1) 1
Czech (1) 1
Danish (1) 1
Hungarian (1) 1
Portuguese (1) 1
Romanian (1) 1
Swedish (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


Psychopharmacology, ISSN 0033-3158, 5/2008, Volume 197, Issue 4, pp. 601 - 611
Neuropeptide S (NPS) and its receptor (NPSR) comprise a recently deorphaned G protein-coupled receptor system. Recent reports implicate NPS in the mediation of... 
GPR154 | Biomedicine | Oxytocin | PGR14 | Vasopressin-related receptor (VRR1) | GPRA | Depression | Pharmacology/Toxicology | Psychiatry | oxytocin | TAIL SUSPENSION TEST | RECEPTOR ANTAGONISTS | PSYCHIATRY | FOOD-INTAKE | VALIDATION | BENZODIAZEPINES | NEUROSCIENCES | vasopressin-related receptor (VRR1) | ANTIDEPRESSANTS | ANXIOLYTIC-LIKE ACTIVITY | PHARMACOLOGY & PHARMACY | ANIMAL-MODEL | depression | INHIBITOR | STRESS-INDUCED HYPERTHERMIA | Chlordiazepoxide - therapeutic use | Calcium - metabolism | Humans | Fear - drug effects | Motor Activity - drug effects | Male | Peptide Fragments - pharmacology | Structure-Activity Relationship | Arousal - drug effects | Dose-Response Relationship, Drug | Receptors, Cell Surface - drug effects | Neuropeptides - pharmacology | Body Temperature Regulation - drug effects | Antidepressive Agents - pharmacology | Chlordiazepoxide - pharmacology | Receptors, Cell Surface - physiology | Alprazolam - pharmacology | Anti-Anxiety Agents - therapeutic use | Anxiety Disorders - drug therapy | Fluoxetine - therapeutic use | Drug Evaluation, Preclinical | Receptors, G-Protein-Coupled - drug effects | Disease Models, Animal | Receptors, G-Protein-Coupled - physiology | Cell Line | Fluoxetine - pharmacology | Alprazolam - therapeutic use | Anxiety - psychology | Anti-Anxiety Agents - pharmacology | Maze Learning - drug effects | Anxiety Disorders - psychology | Neuropeptides - therapeutic use | Antidepressive Agents - therapeutic use | Animals | Mice | Peptide Fragments - therapeutic use | In Vitro Techniques | Neurology | Biochemistry | Pharmacology | Anxieties | Rodents
Journal Article
Current Opinion in Structural Biology, ISSN 0959-440X, 02/2019, Volume 54, p. 189
Journal Article
Nature, ISSN 0028-0836, 01/2019, Volume 565, Issue 7740, pp. 454 - 3
Type-А Y-aminobutyric (GABAA) receptors are ligand-gated chloride channels with a very rich pharmacology. Some of their modulators, including benzodiazepines... 
Drug abuse | γ-Aminobutyric acid A receptors | Lipids | Biochemistry | Crystallography | Modulators | Chloride ions | Proteins | Receptors | γ-Aminobutyric acid | Allosteric properties | Chloride channels | Ion channels | Picrotoxin | Diazepam | Binding | Channel gating | Pharmacology | Electron microscopy | Anesthetics | Benzodiazepines | Alprazolam | Microscopy | Ligands | Binding sites | Pore formation | Bicuculline
Journal Article
Pharmacology, Biochemistry and Behavior, ISSN 0091-3057, 2005, Volume 81, Issue 3, pp. 645 - 656
Journal Article
European Journal of Pharmacology, ISSN 0014-2999, 02/2008, Volume 580, Issue 3, pp. 306 - 313
Previous reports from our laboratory described the sedative activity of hesperidin (hesperetin-7-rhamnoglucoside). This property is greatly increased when the... 
Analgesia | Sedation | Opioid receptors | Hesperidin | Benzodiazepines | opioid receptors | benzodiazepines | DIAZEPAM | ANXIETY | BEHAVIOR | analgesia | HOLE-BOARD | FLAVONOIDS | ANALGESIC ACTIVITY | sedation | hesperidin | CHLORDIAZEPOXIDE | NITRIC-OXIDE | ISOFLAVONOIDS | PHARMACOLOGY & PHARMACY | MICE | Naltrexone - analogs & derivatives | Analgesics - pharmacology | Hypnotics and Sedatives - chemistry | Narcotic Antagonists - administration & dosage | Motor Activity - drug effects | Male | Pain - chemically induced | Dose-Response Relationship, Drug | Receptors, Opioid - physiology | Acetic Acid | Naltrexone - pharmacology | Alprazolam - administration & dosage | Behavior, Animal - drug effects | Alprazolam - pharmacology | Naltrexone - administration & dosage | Benzodiazepines - pharmacology | Morphine - pharmacology | Pain - prevention & control | Flunitrazepam - administration & dosage | Injections, Intraperitoneal | Drug Synergism | Pain Measurement - methods | Animals | Analgesics - chemistry | Narcotic Antagonists - pharmacology | Hesperidin - chemistry | Hesperidin - pharmacology | Benzodiazepines - administration & dosage | Hypnotics and Sedatives - pharmacology | Mice | Morphine - administration & dosage | Flunitrazepam - pharmacology | Alprazolam | Physiological aspects | Glycosides | Analysis | Diazepam
Journal Article
Psychopharmacology, ISSN 0033-3158, 7/2014, Volume 231, Issue 14, pp. 2741 - 2750
Journal Article
Neuropsychopharmacology, ISSN 0893-133X, 2014, Volume 39, Issue 6, pp. 1508 - 1518
Journal Article